HUTCHMED (China) Limited (AIM:HCM)
216.00
+6.00 (2.86%)
Sep 25, 2026, 4:35 PM GMT
HUTCHMED (China) Employees
HUTCHMED (China) had 1,790 employees as of June 30, 2026.
Employees
1,790
Change
n/a
Growth
n/a
Revenue / Employee
231.21K GBP
Profits / Employee
7.53K GBP
Market Cap
1.88B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 1,790 | - | - |
| Dec 31, 2025 | 1,796 | -15 | -0.83% |
| Dec 31, 2024 | 1,811 | -177 | -8.90% |
| Dec 31, 2023 | 1,988 | -37 | -1.83% |
| Dec 31, 2022 | 2,025 | 265 | 15.06% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Haleon | 24,535 |
| Hikma Pharmaceuticals | 9,500 |
| Allergy Therapeutics | 584 |
| ECO Animal Health Group | 213 |
| Shield Therapeutics | 61 |
| Chill Brands Group | 11 |
| Provexis | 2 |
HUTCHMED (China) News
- 3 days ago - HUTCHMED Highlights Clinical Data to be Presented at the ESMO Congress 2026 - GlobeNewsWire
- 5 days ago - Hutchmed price target raised to $18 from $16 at BofA - TheFly
- 16 days ago - HUTCHMED (China) Ltd (HCM) Stock Down 3.2% -- Now Undervalued? GF Score: 81/100 - GuruFocus
- 18 days ago - Hutchmed upgraded to Buy from Hold at HSBC - TheFly
- 23 days ago - HUTCHMED Lands GSK Deal Worth Up to $1.3B for KRAS-EGFR Cancer Therapy - MarketBeat
- 23 days ago - Hutchmed upgraded to Buy from Hold at Daiwa - TheFly
- 23 days ago - Hutchmed rises 13.7% - TheFly
- 23 days ago - HUTCHMED Stock (HCM) Rallies Over 15% on a Major Licensing Deal - TipRanks